Correlation Between Luye Pharma and Amgen

Can any of the company-specific risk be diversified away by investing in both Luye Pharma and Amgen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Luye Pharma and Amgen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Luye Pharma Group and Amgen Inc, you can compare the effects of market volatilities on Luye Pharma and Amgen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Luye Pharma with a short position of Amgen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Luye Pharma and Amgen.

Diversification Opportunities for Luye Pharma and Amgen

-0.9

Correlation Coefficient

Luye Pharma  Amgen

Pay attention - limited upside

The 3 months correlation between Luye and Amgen is -0.9. Overlapping area represents the amount of risk that can be diversified away by holding Luye Pharma Group and Amgen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amgen Inc and Luye Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Luye Pharma Group are associated (or correlated) with Amgen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amgen Inc has no effect on the direction of Luye Pharma i.e., Luye Pharma and Amgen go up and down completely randomly.

Pair Corralation between Luye Pharma and Amgen

Assuming the 90 days horizon Luye Pharma Group is expected to generate 0.78 times more return on investment than Amgen. However, Luye Pharma Group is 1.29 times less risky than Amgen. It trades about 0.13 of its potential returns per unit of risk. Amgen Inc is currently generating about -0.14 per unit of risk. If you would invest  31.00  in Luye Pharma Group on October 25, 2024 and sell it today you would earn a total of  3.00  from holding Luye Pharma Group or generate 9.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	98.33%
Values	Daily Returns

Luye Pharma Group  vs.  Amgen Inc

Luye Pharma Group

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Luye Pharma Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical indicators, Luye Pharma may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Amgen Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amgen Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Luye Pharma and Amgen

The main advantage of trading using opposite Luye Pharma and Amgen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Luye Pharma position performs unexpectedly, Amgen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will offset losses from the drop in Amgen's long position.

The idea behind Luye Pharma Group and Amgen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.